Delivery Order SPE2DB24D9238-SPE2DB25FDRAN
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,312.85 to DMS Pharmaceutical Group Inc. for the supply of Botox 100 unit vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order carries an ultimate completion date of September 24, 2025, and represents a specific fulfillment under the company's broader procurement...
- The Defense Logistics Agency awarded a $12,937.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The award, made on September 10, 2025, with an ultimate completion date of October 1, 2025, was issued without set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a $4,625.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 unit vials. The award, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency has awarded a delivery order valued at $15,524.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion...
- The Defense Logistics Agency awarded a delivery order valued at $64,685 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200-unit vials. The contract, awarded on September 10, 2025, utilizes firm fixed-price pricing with an ultimate completion date of October 1, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The contract, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Illinois location. This...
- The Defense Logistics Agency awarded a delivery order valued at $9,251.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract, awarded on May 2, 2025, with an ultimate completion date of May 23, 2025, carries firm fixed-price terms with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under...
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a single-award transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no...
- The Defense Logistics Agency awarded a delivery order valued at $2,775.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 unit vials. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract was awarded...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $18,502.80 to DMS Pharmaceutical Group Inc. for the supply of Botox 100 unit vials, with performance scheduled for completion by September 16, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDRANDelivery Order
The Defense Logistics Agency awarded a $22,203.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Botox 100-unit vials, with an ultimate completion date of September 30, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS's larger single-award Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in government procurement markets. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Defense Department healthcare systems. This particular delivery order for Botox represents one of numerous pharmaceutical product acquisitions DLA issues through the SPE2DB program, which encompasses medications ranging from oncology treatments to vaccines and specialty injections. The vendor's consistent track record securing contracts without set-aside designations demonstrates its competitive positioning and the trust DLA has placed in its pharmaceutical distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.2k | 9/9/25 |